Skip to main navigation Skip to search Skip to main content

A therapeutic dilemma between the two "R" s: Additional rituximab or radiotherapy for limited, nonbulky diffuse large B-cell lymphoma

  • Sungkyunkwan University

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)57-58
Number of pages2
JournalKorean Journal of Hematology
Volume46
Issue number1
DOIs
StatePublished - Mar 2011
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this